NCT00004166View on ClinicalTrials.gov

Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 1999

Primary Completion Date

January 31, 2003

Study Completion Date

January 31, 2003

Conditions
Ovarian CancerQuality of Life
Interventions
DRUG

amifostine trihydrate

PROCEDURE

quality-of-life assessment

Trial Locations (1)

60611

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Northwestern University

OTHER